EASD: Benefits of T2D Triple Therapy Hold Up Over Time (CME/CE)

(MedPage Today) -- Three-year follow-up of EDICT trial still supports combo therapy
via EASD: Benefits of T2D Triple Therapy Hold Up Over Time (CME/CE)
by